Please select the option that best describes you:
Topics:
Rheumatology • Interstitial lung disease • Pulmonology • Diffuse Parenchymal Lung Disease • CTD-ILD
How do you approach management of ILD in the presence of weakly positive RF and ANA but no other objective systemic findings of connective tissue disease?
Is this managed as CTD-ILD with immunosuppressive +/- anti-fibrotic agents?